Apollo Health Ventures is unveiling a new start-up: Nula Therapeutics, whose funding comes mostly from the Advanced Research ...
The nuclear envelope (NE) is a dynamic and selective barrier that organizes genome function and nucleocytoplasmic communication, and its structural deterioration is a hallmark of aging associated with ...
Backed by Apollo Health Ventures, Nula aims to transform treatment of metabolic dysfunctionARPA-H award brings total funding ...